EXOZeXoZymes Inc. Common Stock
7.150USD+11.72%Mkt Cap: 66.36M $P/E: —3d ago
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap66.36M $
Enterprise Value60.77M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.16M $
Revenue/Share—
Last Price7.150 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.92
EV/Revenue—
P/S—
P/B17.87
EPS (TTM)-1.33
EPS (Forward)—
52W Range
4.35020% of range18.40
52W High18.40 USD
52W Low4.350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-269.59%
ROA-153.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.50M $
CapEx (TTM)169.92K $
FCF Margin—
FCF Yield-6.16%
Net Debt-4.57M $
Net Debt/EBITDA0.45
Balance Sheet
Debt/Equity0.37
Current Ratio3.81
Quick Ratio3.63
Book Value/Sh0.3940 USD
Cash/Share0.6090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.28M
Float7.08M
Insiders64.53%
Institutions1.34%
Short Interest
Short Ratio1.6d
Short % Float0.44%
Short % Out.0.24%
Shares Short21.89K
Short (prev mo.)15.72K
Technical
SMA 506.404 (+11.7%)
SMA 2009.722 (-26.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)7.37K
Avg Vol (10d)5.66K
Technical Indicators
RSI (14)67.3
MACD0.1510
MACD Signal-0.1561
MACD Hist.+0.3071
BB Upper7.184 USD
BB Middle5.454 USD
BB Lower3.724 USD
BB Width63.46%
ATR (14)0.6052 USD
Vol Ratio (20d)1.60x